Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03035630
Title Sunitinib Followed by Avelumab or the Reverse for Metastatic Renal Cell Carcinoma
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors Guru Sonpavde
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.